Psyence Biomedical Ltd Stock Beta
| PBMWW Stock | 0.01 0.0006 7.50% |
Psyence Biomedical Ltd fundamentals help investors to digest information that contributes to Psyence Biomedical's financial success or failures. It also enables traders to predict the movement of Psyence Stock. The fundamental analysis module provides a way to measure Psyence Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Psyence Biomedical stock.
Psyence | Beta |
Psyence Biomedical Ltd Company Beta Analysis
Psyence Biomedical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Psyence Biomedical Beta | -0.42 |
Most of Psyence Biomedical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Psyence Biomedical Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Psyence Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Psyence Biomedical is extremely important. It helps to project a fair market value of Psyence Stock properly, considering its historical fundamentals such as Beta. Since Psyence Biomedical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Psyence Biomedical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Psyence Biomedical's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Psyence Biomedical Ltd has a Beta of -0.425. This is 149.42% lower than that of the Healthcare sector and 130.58% lower than that of the Biotechnology industry. The beta for all United States stocks is 183.33% higher than that of the company.
Psyence Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Psyence Biomedical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Psyence Biomedical could also be used in its relative valuation, which is a method of valuing Psyence Biomedical by comparing valuation metrics of similar companies.Psyence Biomedical is currently under evaluation in beta category among its peers.
As returns on the market increase, returns on owning Psyence Biomedical are expected to decrease at a much lower rate. During the bear market, Psyence Biomedical is likely to outperform the market.
Psyence Fundamentals
| Return On Asset | -1.26 | ||||
| Number Of Shares Shorted | 45.99 K | ||||
| EBITDA | (2.75 M) | ||||
| Book Value Per Share | (0.82) X | ||||
| Beta | -0.42 |
About Psyence Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Psyence Biomedical Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Psyence Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Psyence Biomedical Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Psyence Stock Analysis
When running Psyence Biomedical's price analysis, check to measure Psyence Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence Biomedical is operating at the current time. Most of Psyence Biomedical's value examination focuses on studying past and present price action to predict the probability of Psyence Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence Biomedical's price. Additionally, you may evaluate how the addition of Psyence Biomedical to your portfolios can decrease your overall portfolio volatility.